Expression and gene copy number analysis of ERBB2 oncogene in prostate cancer.
about
Molecular alterations in prostate cancer as diagnostic, prognostic, and therapeutic targetsExpression and copy number analysis of TRPS1, EIF3S3 and MYC genes in breast and prostate cancerSuppressor of cytokine signaling (SOCS)-1 is expressed in human prostate cancer and exerts growth-inhibitory function through down-regulation of cyclins and cyclin-dependent kinasesMolecular pathology of prostate cancerSuppressor of cytokine signaling-3 antagonizes cAMP effects on proliferation and apoptosis and is expressed in human prostate cancerDual activation of pathways regulated by steroid receptors and peptide growth factors in primary prostate cancer revealed by Factor Analysis of microarray data.Matriptase is involved in ErbB-2-induced prostate cancer cell invasionLentiviruses with trastuzumab bound to their envelopes can target and kill prostate cancer cells.Androgen-independent prostate cancer: potential role of androgen and ErbB receptor signal transduction crosstalkGene amplification and protein expression of EGFR and HER2 by chromogenic in situ hybridisation and immunohistochemistry in atypical adenomatous hyperplasia and adenocarcinoma of the lung.Expression of the epidermal growth factor receptor family in prostate carcinoma before and during androgen-independence.Prognostic value of Her-2/neu and DNA index for progression, metastasis and prostate cancer-specific death in men with long-term follow-up after radical prostatectomyHER2 gene amplification in patients with prostate cancer: Evaluating a CISH-based method.AGE-modified basement membrane cooperates with Endo180 to promote epithelial cell invasiveness and decrease prostate cancer survival.Bifunctional phage-based pretargeted imaging of human prostate carcinoma.Androgen receptor expression in prostate cancer cells is suppressed by activation of epidermal growth factor receptor and ErbB2.Myc confers androgen-independent prostate cancer cell growth.Prostate cancer cell lines lack amplification: overexpression of HER2.Up-regulated expression of ADAM17 in human colon carcinoma: co-expression with EGFR in neoplastic and endothelial cells.Phosphorylation of both EGFR and ErbB2 is a reliable predictor of prostate cancer cell proliferation in response to EGF.ErbB2 Signaling Increases Androgen Receptor Expression in Abiraterone-Resistant Prostate Cancer.Improved Aptamers for the Diagnosis and Potential Treatment of HER2-Positive Cancer.Long-term assessment of prostate cancer progression free survival: evaluation of pathological parameters, nuclear shape and molecular biomarkers of pathogenesis.Imaging primary prostate cancer with 11C-Choline PET/CT: relation to tumour stage, Gleason score and biomarkers of biologic aggressiveness.Potentiation of antitumour activity of docetaxel by combination with trastuzumab in a human prostate cancer xenograft model and underlying mechanisms.Differential expression of 37 selected genes in hormone-refractory prostate cancer using quantitative taqman real-time RT-PCR.HER3 is required for the maintenance of neuregulin-dependent and -independent attributes of malignant progression in prostate cancer cells.Detecting differential copy number variation between groups of samples.Reliability of a composite measure of social inclusion for people with psychiatric disabilities.Expression patterns of potential therapeutic targets in prostate cancer.
P2860
Q24629083-3E896C37-3969-403E-ABFB-E41F17CDE8F5Q24645931-0ABD19A2-2FDA-487E-B6C5-84B6D27C1836Q24656365-5B8B6097-9B6A-46E2-A1CD-94A22696AFBAQ24672410-3C516A1F-A923-4C17-A209-FA910A051F62Q24677026-D8970046-A84C-46DB-A104-886E36FE82A3Q24817218-E882B02F-71C8-4BDA-A015-81FAC9220D1BQ34358331-2B72E22C-D9DF-4563-8D5E-090980E56895Q34976249-6AB1A8F3-A6EC-462E-A353-EF3BF1C76E01Q35092971-C8F3F401-08CB-4148-B61E-6E8C75899DA4Q35588760-2D9538D7-E402-4A0A-B919-E8571D07344CQ36696600-97163423-9ADC-433D-93DF-F2288CD75B01Q37120344-90D93B6F-CEE4-4905-B6F4-17A55D0DFAA8Q37582166-0B9F4C0E-3A8B-42D7-A6CB-82A67685C5D0Q38939314-813331C5-3C15-4F64-AE23-6D4A2BC0109DQ39805831-F04E0B14-ED77-426B-98A4-1A520CD1C997Q39843676-545E7115-4903-4114-B64C-F844AA738B34Q40271517-5E2477A4-83E3-4681-86FB-55B6C148DEC1Q40382023-D06E858C-E206-46B9-BC3A-2E88A12265A3Q40393668-637F6219-3249-4981-8663-3F3C3F71680FQ40456737-C7CDDF51-38E6-4CDC-93F4-0FAEB223E2E6Q41768007-01BFF822-BE26-4934-96FE-3C557874EA8DQ42070603-54132896-7ACE-463A-9422-0D9A205F4A1BQ42120683-50572233-16C1-4EF0-A5EE-22257FDCA960Q42423216-685798FA-9BD5-4C64-B401-E915B2008692Q43199031-53A02DAA-AA91-4AAF-9D73-D18302224D09Q45150551-6FBC21B3-27DA-47DE-A5CD-CCAF5A250A94Q45967686-36601627-1BB7-496E-95D7-33668EF17E56Q47179702-031C153E-F4F0-4AFD-AEC8-0AC4072CBDE5Q51893327-4402A6EC-0465-45FF-B3F8-CC35B4136D4AQ53883291-9BC7E357-2BC7-4FB8-9D2B-4B9477C0FC17
P2860
Expression and gene copy number analysis of ERBB2 oncogene in prostate cancer.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Expression and gene copy number analysis of ERBB2 oncogene in prostate cancer.
@ast
Expression and gene copy number analysis of ERBB2 oncogene in prostate cancer.
@en
type
label
Expression and gene copy number analysis of ERBB2 oncogene in prostate cancer.
@ast
Expression and gene copy number analysis of ERBB2 oncogene in prostate cancer.
@en
prefLabel
Expression and gene copy number analysis of ERBB2 oncogene in prostate cancer.
@ast
Expression and gene copy number analysis of ERBB2 oncogene in prostate cancer.
@en
P2093
P2860
P1476
Expression and gene copy number analysis of ERBB2 oncogene in prostate cancer.
@en
P2093
Jorma J Isola
Kimmo J Savinainen
Marika J Linja
Outi R Saramäki
Tapio Visakorpi
Teuvo L J Tammela
P2860
P304
P356
10.1016/S0002-9440(10)64377-5
P407
P577
2002-01-01T00:00:00Z